QuickLinks -- Click here to rapidly navigate through this document
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Amendment No. 1 to the Registration Statement on Form S-4 of our report (which contains an explanatory paragraph relating to BioPharmX Corporation's ability to continue as a going concern as described in Note 2 to the consolidated financial statements) dated March 27, 2020, relating to the consolidated financial statements of BioPharmX Corporation, which appears in the Annual Report on Form 10-K of BioPharmX Corporation for the year ended January 31, 2020. We also consent to the reference of our firm under the heading "Experts" in such Registration Statement.
/s/ BPM LLP
San Jose, California
March 27, 2020
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM